Salimov R M, Kovalev G I
Eksp Klin Farmakol. 2008 May-Jun;71(3):3-5.
We have studied the effects of nicotine (0.125, 0.25, and 0.5 mg/kg) and mecamylamine (0.5, 1.5, and 3 mg/kg) in comparison to reference cognition-enhancing drugs piracetam (100 and 300 mg/kg) and meclofenoxate (20, 50, and 100 mg/kg) administered to male C57BL mice intraperitoneally 30 min prior to behavioral test. The behavioral drug effect was evaluated as influencing the activity in visiting arms of a closed plus-maze. Piracetam (300 mg/kg) and meclofenoxate (100 mg/kg) improved the exploratory activity. Mecamylamine (0.5 mg/kg) also improved the exploratory activity, while nicotine (0.5 mg/kg) deteriorated it.
我们研究了尼古丁(0.125、0.25和0.5毫克/千克)和美加明(0.5、1.5和3毫克/千克)的作用,并与在行为测试前30分钟腹腔注射给雄性C57BL小鼠的参比认知增强药物吡拉西坦(100和300毫克/千克)和甲氯芬酯(20、50和100毫克/千克)进行比较。行为药物效应通过对封闭十字迷宫各臂活动的影响来评估。吡拉西坦(300毫克/千克)和甲氯芬酯(100毫克/千克)可改善探索活动。美加明(0.5毫克/千克)也可改善探索活动,而尼古丁(0.5毫克/千克)则使其恶化。